Optimal treatment strategies for stage I non-small cell lung cancer in veterans with pulmonary and cardiac comorbidities.

Keith M Sigel Chung Yin KongSadiq RehmaniSusan BatesMichael GouldKimberly StoneMinal KaleYeun-Hee ParkKristina CrothersFaiz BhoraJuan Wisnivesky

Published in: PloS one (2021)

The harm/benefit ratio of treatments for stage I NSCLC among Veterans may vary according to COPD severity and the presence of CAD. This information can be used to direct future research study design for Veterans with stage I lung cancer and COPD and/or CAD.

Keyphrases

chronic obstructive pulmonary disease
coronary artery disease
lung function
small cell lung cancer
pulmonary hypertension
left ventricular
healthcare
current status
advanced non small cell lung cancer
health information
air pollution